What is the current Flowable Hemostats market size?

The Flowable Hemostats market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Flowable Hemostats market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Flowable Hemostats market?

Increasing demand for minimally invasive surgeries drives the market forward.

What challenges does the Flowable Hemostats market face?

Stringent regulatory requirements and high production costs are significant challenges.

Which regions are the leaders in the Flowable Hemostats market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Flowable Hemostats market?

Top companies include Johnson & Johnson and Medtronic, among others.

What future opportunities exist in the Flowable Hemostats market?

Emerging economies and advancements in technology offer future growth opportunities.

How does technology impact the Flowable Hemostats market?

Advances in biomaterials and biotechnology improve product efficacy and safety.

What is the current regulatory landscape for the Flowable Hemostats market?

The market is regulated by authorities such as the FDA and CE Mark.

What is the future outlook for the Flowable Hemostats market?

The future outlook is positive, driven by increasing demand and innovation.

Flowable Hemostats Growth Opportunities & Strategic Forecast 2033

Flowable Hemostats by Application (General Surgery, Cardiac Surgery, Vascular Surgery, Neuro and Spine Surgery, Orthopedic Surgery, Others), by Types (Porcine Gelatin, Bovine Gelatin), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 71

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 71

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Flowable Hemostats Market Overview

The Flowable Hemostats market refers to the global market for flowable hemostatic agents used to control bleeding during surgical procedures. As a critical component of the hemostasis market, the flowable hemostats market size is estimated to be around $1.3 billion in 2025. The growth outlook for the flowable hemostats market is promising, with a market forecast indicating a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period. The industry expansion is driven by increasing demand for effective hemostatic agents, advancements in medical technology, and the rising number of surgical procedures. The scope of the flowable hemostats market encompasses various types of hemostatic agents, including gelatin-based, collagen-based, and polysaccharide-based products, used in surgical applications such as cardiovascular, neurological, and orthopedic surgeries.

Loading chart…

The growth of the flowable hemostats market is driven by key forces such as technology shifts, with the development of new hemostatic agents and regulatory approvals. The largest region for the flowable hemostats market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing demand for hemostatic agents in countries such as China and India. The competitive intensity of the market is high, with major players such as Johnson & Johnson and Baxter International, and new entrants are expected to drive innovation and growth in the market. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and market dynamics to make strategic decisions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.35 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter International; Teleflex Incorporated
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Flowable Hemostats market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Flowable Hemostats market size and growth forecast.

Growth Drivers2 items

Advances in biotechnology and biomaterials have led to the development of innovative Flowable Hemostats products with improved efficacy and safety profiles, driving adoption rates among healthcare professionals.

Increasing minimally invasive surgical procedures and rising trauma cases have fueled the demand for effective hemostatic agents, contributing to the growth of the Flowable Hemostats market.

Restraints2 items

Stringent regulatory requirements and high research and development costs may hinder the entry of new players in the Flowable Hemostats market, limiting competition and innovation.

The high cost of certain Flowable Hemostats products and reimbursement issues may restrict their adoption in price-sensitive markets, affecting the overall growth of the Flowable Hemostats market size.

Opportunities2 items

Emerging economies with growing healthcare infrastructure present significant opportunities for Flowable Hemostats market players to expand their presence and increase their market share.

The increasing focus on personalized medicine and patient-specific treatments may lead to the development of customized Flowable Hemostats products, driving growth and innovation in the market.

Challenges2 items

The Flowable Hemostats market faces challenges related to supply chain disruptions and raw material shortages, which can impact product availability and pricing strategies.

The complexity of surgical procedures and the need for specialized training may limit the adoption of certain Flowable Hemostats products, affecting the growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment of the Flowable Hemostats market refers to the various medical procedures and surgeries where these products are utilized to control bleeding. This segment is crucial in understanding the Flowable Hemostats segmentation as it directly influences the market size. The application segment is further divided into subtypes, including surgical procedures, trauma cases, and other medical applications. Each subtype has its own set of requirements and preferences, driving the demand for specific types of flowable hemostats.

The Types segment of the Flowable Hemostats market encompasses the different product categories available, such as gelatin-based, collagen-based, and polysaccharide-based hemostats. This segmentation is vital in determining the market taxonomy, as each type has its own strengths, weaknesses, and areas of application. The types segment is also influenced by factors such as efficacy, safety, and cost, which in turn affect the overall market size. Understanding the types segment is essential for manufacturers to develop products that meet the specific needs of healthcare professionals and patients.

Flowable Hemostats Segmentation Breakdown10 items

Application

General Surgery

Cardiac Surgery

Vascular Surgery

Neuro and Spine Surgery

Orthopedic Surgery

Others

Types

Porcine Gelatin

Bovine Gelatin

Regional Insights

Loading chart…

The Flowable Hemostats market growth is anticipated to be driven by various factors across different regions. North America is the largest region, accounting for approximately 40% of the market share, driven by key factors such as high adoption rates of advanced hemostatic agents, favorable policies supporting medical innovation, and significant investments in healthcare infrastructure.

The fastest-growing region is expected to be Asia Pacific, with a regional forecast indicating a growth rate driven by increasing demand for effective hemostatic solutions, expanding demographics with a growing geriatric population, and improving ecosystem maturity with advancements in medical technology.

In Europe, key drivers include stringent regulatory policies promoting the use of safe and effective hemostatic agents, growing investments in research and development, and established infrastructure supporting the adoption of advanced medical technologies. Latin America and Middle East & Africa are also expected to contribute to the Flowable Hemostats market growth, driven by increasing awareness of hemostatic solutions, expanding healthcare infrastructure, and growing demand for effective treatments.

Competitive Landscape

The Flowable Hemostats market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Flowable Hemostats competitive landscape is driven by companies that leverage these competitive levers to gain market share. Global players tend to have an advantage in terms of distribution and regulatory approvals, while local companies focus on pricing and customization to compete.

Companies in the Flowable Hemostats market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They also focus on technology, service model, channel strength, customization, and cost advantages to stand out from the competition. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their position in the market. Some of the companies' strategies include:

Johnson & Johnson: regional expansion

Baxter International: premium pricing

Teleflex Incorporated: innovation pipeline

Johnson & Johnson: local manufacturing

Baxter International: OEM tie-ups

Teleflex Incorporated: vertical integration

Key Flowable Hemostats Companies3 items

Johnson & Johnson

Baxter International

Teleflex Incorporated

Market Ecosystem

The Flowable Hemostats ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. It involves the creation and capture of value through the development, manufacturing, and distribution of flowable hemostats, with technology providers and suppliers at the upstream end, and end users, such as medical professionals and healthcare institutions, at the downstream end. The value chain analysis of this ecosystem highlights the interactions and interdependencies among various stakeholders, influencing the overall efficiency and effectiveness of the market.

Raw material/component suppliers — providing raw materials

OEMs / manufacturers — designing and manufacturing products

Technology providers — developing underlying technologies

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering post-sales support

End users / buyers — utilizing flowable hemostats in medical procedures

Regulators/standards bodies — establishing and enforcing industry standards

In the Flowable Hemostats ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and compliance requirements. Dependency risks arise from input constraints, such as raw material availability, and standards, which can impact product development and distribution. Switching costs and partnerships are also crucial, as companies may need to adapt to new technologies or form alliances to ensure interoperability. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market demands, underscoring the need for a nuanced understanding of the Flowable Hemostats ecosystem.

Recent Industry Insights

The Flowable Hemostats industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in medical technology and increasing demand for effective hemostasis solutions. Recent partnerships between key market players have focused on expanding product portfolios and enhancing distribution networks. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and improve competitiveness.

Additionally, several product launches have been observed, featuring innovative flowable hemostat formulations with improved efficacy and reduced complications. Regulatory changes have also influenced the industry, with updated guidelines and standards for hemostat product approval and usage. Furthermore, a shift in consumer and enterprise trends towards minimally invasive procedures has fueled the demand for advanced flowable hemostats, with companies responding through funding rounds and expansions to support research and development.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Flowable Hemostats market outlook is highly attractive, driven by increasing demand for effective hemostasis solutions in surgical procedures. The competitive intensity is moderate, with key players focusing on product innovation and strategic partnerships. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is dynamic, with ongoing research and development aimed at improving product efficacy and safety. However, the demand–supply balance is a key concern, with potential shortages of certain products. Key risk factors include regulatory challenges, pricing pressures, and intense competition. Overall, the market offers significant opportunities for growth and innovation, but players must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Flowable Hemostats Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Flowable Hemostats Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Flowable Hemostats Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. General Surgery

6.1.2. Cardiac Surgery

6.1.3. Vascular Surgery

6.1.4. Neuro and Spine Surgery

6.1.5. Orthopedic Surgery

6.1.6. Others

6.2. Global Flowable Hemostats Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Porcine Gelatin

6.2.2. Bovine Gelatin

6.3. Global Flowable Hemostats Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Flowable Hemostats Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Flowable Hemostats Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Flowable Hemostats Market Competition by Key Manufacturers

8.1. Global Flowable Hemostats Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Flowable Hemostats: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Baxter International

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Teleflex Incorporated

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Flowable Hemostats Market

Figure 4: Global Flowable Hemostats Market: Drivers

Figure 5: Global Flowable Hemostats Market: Challenges

Figure 6: Global Flowable Hemostats Market: Trends

Figure 7: Global Flowable Hemostats Market: Opportunity

Figure 8: Global Flowable Hemostats Market: Restraint

Figure 9: Global Flowable Hemostats Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Flowable Hemostats Market Value (USD Million) By Region

Figure 15: Global Flowable Hemostats Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Flowable Hemostats Market Value (USD Million) By Region

Figure 23: Global Flowable Hemostats Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global Flowable Hemostats Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Flowable Hemostats Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Flowable Hemostats Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Flowable Hemostats Market Value (USD Million) By Region

Table 10: Global Flowable Hemostats Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Flowable Hemostats Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Flowable Hemostats Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Flowable Hemostats Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: Baxter International Basic Information And Sales Area

Table 33: Baxter International. Products Portfolio

Table 34: Teleflex Incorporated Basic Information And Sales Area

Table 35: Teleflex Incorporated. Products Portfolio

Table 36: Global Market Value (USD Million) (2025-2032) By Application

Table 37: Global Market Share (%) By Application (2032)

Table 38: Global Market Value (USD Million) (2025-2032) By Types

Table 39: Global Market Share (%) By Types (2032)

Table 40: Global Flowable Hemostats Market Value (USD Million) By Region

Table 41: Global Flowable Hemostats Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Million) (2025-2032) By Country

Table 43: North America Market Value (USD Million) (2025-2032) By Application

Table 44: North America Market Value (USD Million) (2025-2032) By Types

Table 45: Europe Market Value (USD Million) (2025-2032) By Country

Table 46: Europe Market Value (USD Million) (2025-2032) By Application

Table 47: Europe Market Value (USD Million) (2025-2032) By Types

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 51: South America Market Value (USD Million) (2025-2032) By Country

Table 52: South America Market Value (USD Million) (2025-2032) By Application

Table 53: South America Market Value (USD Million) (2025-2032) By Types

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Flowable Hemostats Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.35 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter International; Teleflex Incorporated
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing minimally invasive surgical procedures and rising trauma cases have fueled the demand for effective hemostatic agents, contributing to the growth of the Flowable Hemostats market.

Restraints2 items

Stringent regulatory requirements and high research and development costs may hinder the entry of new players in the Flowable Hemostats market, limiting competition and innovation.

Opportunities2 items

Emerging economies with growing healthcare infrastructure present significant opportunities for Flowable Hemostats market players to expand their presence and increase their market share.

The increasing focus on personalized medicine and patient-specific treatments may lead to the development of customized Flowable Hemostats products, driving growth and innovation in the market.

Challenges2 items

The Flowable Hemostats market faces challenges related to supply chain disruptions and raw material shortages, which can impact product availability and pricing strategies.

The complexity of surgical procedures and the need for specialized training may limit the adoption of certain Flowable Hemostats products, affecting the growth forecast of the market.

Market Segmentation

Loading chart…

Flowable Hemostats Segmentation Breakdown10 items

Application

General Surgery

Cardiac Surgery

Vascular Surgery

Neuro and Spine Surgery

Orthopedic Surgery

Others

Types

Porcine Gelatin

Bovine Gelatin

Regional Insights

Loading chart…

Competitive Landscape

Johnson & Johnson: regional expansion

Baxter International: premium pricing

Teleflex Incorporated: innovation pipeline

Johnson & Johnson: local manufacturing

Baxter International: OEM tie-ups

Teleflex Incorporated: vertical integration

Key Flowable Hemostats Companies3 items

Johnson & Johnson

Baxter International

Teleflex Incorporated

Market Ecosystem

Raw material/component suppliers — providing raw materials

OEMs / manufacturers — designing and manufacturing products

Technology providers — developing underlying technologies

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering post-sales support

End users / buyers — utilizing flowable hemostats in medical procedures

Regulators/standards bodies — establishing and enforcing industry standards

Recent Industry Insights

Analyst Overview

Table of Contents